|
US2647121A
(en)
|
1951-02-02 |
1953-07-28 |
Ruth P Jacoby |
Diamine-bis-acetamides
|
|
US2819718A
(en)
|
1953-07-16 |
1958-01-14 |
Isidore H Goldman |
Drainage tube
|
|
US2717909A
(en)
|
1953-09-24 |
1955-09-13 |
Monsanto Chemicals |
Hydroxyethyl-keryl-alkylene-ammonium compounds
|
|
US2844629A
(en)
|
1956-04-25 |
1958-07-22 |
American Home Prod |
Fatty acid amides and derivatives thereof
|
|
US3096560A
(en)
|
1958-11-21 |
1963-07-09 |
William J Liebig |
Process for synthetic vascular implants
|
|
GB1072118A
(en)
|
1962-12-01 |
1967-06-14 |
Sandoz Ag |
Amides of aminopropionic acid
|
|
FR1378382A
(fr)
|
1962-12-01 |
1964-11-13 |
Sandoz Sa |
Amides de l'acide amino-propionique, utilisables en particulier pour le traitement des fibres textiles
|
|
JPS5141663B1
(ru)
|
1966-03-12 |
1976-11-11 |
|
|
|
JPS4822365B1
(ru)
|
1968-10-25 |
1973-07-05 |
|
|
|
NL143127B
(nl)
|
1969-02-04 |
1974-09-16 |
Rhone Poulenc Sa |
Versterkingsorgaan voor een defecte hartklep.
|
|
US3614955A
(en)
|
1970-02-09 |
1971-10-26 |
Medtronic Inc |
Standby defibrillator and method of operation
|
|
US3614954A
(en)
|
1970-02-09 |
1971-10-26 |
Medtronic Inc |
Electronic standby defibrillator
|
|
JPS5024216Y1
(ru)
|
1970-12-29 |
1975-07-21 |
|
|
|
JPS5024216B1
(ru)
|
1970-12-29 |
1975-08-14 |
|
|
|
US3945052A
(en)
|
1972-05-01 |
1976-03-23 |
Meadox Medicals, Inc. |
Synthetic vascular graft and method for manufacturing the same
|
|
US3805301A
(en)
|
1972-07-28 |
1974-04-23 |
Meadox Medicals Inc |
Tubular grafts having indicia thereon
|
|
JPS49127908A
(ru)
|
1973-04-20 |
1974-12-07 |
|
|
|
JPS5624664B2
(ru)
|
1973-06-28 |
1981-06-08 |
|
|
|
US4013507A
(en)
|
1973-09-18 |
1977-03-22 |
California Institute Of Technology |
Ionene polymers for selectively inhibiting the vitro growth of malignant cells
|
|
JPS5123537A
(ja)
|
1974-04-26 |
1976-02-25 |
Adeka Argus Chemical Co Ltd |
Kasozaisoseibutsu
|
|
GB1527592A
(en)
|
1974-08-05 |
1978-10-04 |
Ici Ltd |
Wound dressing
|
|
US3995623A
(en)
|
1974-12-23 |
1976-12-07 |
American Hospital Supply Corporation |
Multipurpose flow-directed catheter
|
|
JPS5813576B2
(ja)
|
1974-12-27 |
1983-03-14 |
アデカ ア−ガスカガク カブシキガイシヤ |
安定化された合成高分子組成物
|
|
US4281669A
(en)
|
1975-05-09 |
1981-08-04 |
Macgregor David C |
Pacemaker electrode with porous system
|
|
DE2520814A1
(de)
|
1975-05-09 |
1976-11-18 |
Bayer Ag |
Lichtstabilisierung von polyurethanen
|
|
JPS5210847A
(en)
|
1975-07-16 |
1977-01-27 |
Nippon Steel Corp |
Pinch roll
|
|
US4096860A
(en)
|
1975-10-08 |
1978-06-27 |
Mclaughlin William F |
Dual flow encatheter
|
|
CA1069652A
(en)
|
1976-01-09 |
1980-01-15 |
Alain F. Carpentier |
Supported bioprosthetic heart valve with compliant orifice ring
|
|
US4134402A
(en)
|
1976-02-11 |
1979-01-16 |
Mahurkar Sakharam D |
Double lumen hemodialysis catheter
|
|
US4072146A
(en)
|
1976-09-08 |
1978-02-07 |
Howes Randolph M |
Venous catheter device
|
|
US4335723A
(en)
|
1976-11-26 |
1982-06-22 |
The Kendall Company |
Catheter having inflatable retention means
|
|
US4099528A
(en)
|
1977-02-17 |
1978-07-11 |
Sorenson Research Co., Inc. |
Double lumen cannula
|
|
US4140126A
(en)
|
1977-02-18 |
1979-02-20 |
Choudhury M Hasan |
Method for performing aneurysm repair
|
|
US4265745A
(en)
|
1977-05-25 |
1981-05-05 |
Teijin Limited |
Permselective membrane
|
|
US4182833A
(en)
|
1977-12-07 |
1980-01-08 |
Celanese Polymer Specialties Company |
Cationic epoxide-amine reaction products
|
|
US4180068A
(en)
|
1978-04-13 |
1979-12-25 |
Motion Control, Incorporated |
Bi-directional flow catheter with retractable trocar/valve structure
|
|
DE2960875D1
(en)
|
1978-04-19 |
1981-12-10 |
Ici Plc |
A method of preparing a tubular product by electrostatic spinning
|
|
US4284459A
(en)
|
1978-07-03 |
1981-08-18 |
The Kendall Company |
Method for making a molded catheter
|
|
US4227533A
(en)
|
1978-11-03 |
1980-10-14 |
Bristol-Myers Company |
Flushable urinary catheter
|
|
US4375817A
(en)
|
1979-07-19 |
1983-03-08 |
Medtronic, Inc. |
Implantable cardioverter
|
|
US5132418A
(en)
|
1980-02-29 |
1992-07-21 |
University Patents, Inc. |
Process for preparing polynucleotides
|
|
US4458066A
(en)
|
1980-02-29 |
1984-07-03 |
University Patents, Inc. |
Process for preparing polynucleotides
|
|
US4500707A
(en)
|
1980-02-29 |
1985-02-19 |
University Patents, Inc. |
Nucleosides useful in the preparation of polynucleotides
|
|
DE3010841A1
(de)
|
1980-03-21 |
1981-10-08 |
Ulrich Dr.med. 6936 Haag Uthmann |
Katheder
|
|
US4308085A
(en)
|
1980-07-28 |
1981-12-29 |
Jenoptik Jena Gmbh |
Process for the preparation of high molecular thermoplastic epoxide-amine-polyadducts
|
|
US4415732A
(en)
|
1981-03-27 |
1983-11-15 |
University Patents, Inc. |
Phosphoramidite compounds and processes
|
|
US4973679A
(en)
|
1981-03-27 |
1990-11-27 |
University Patents, Inc. |
Process for oligonucleo tide synthesis using phosphormidite intermediates
|
|
US4668777A
(en)
|
1981-03-27 |
1987-05-26 |
University Patents, Inc. |
Phosphoramidite nucleoside compounds
|
|
US4339369A
(en)
|
1981-04-23 |
1982-07-13 |
Celanese Corporation |
Cationic epoxide-amine reaction products
|
|
US4401796A
(en)
|
1981-04-30 |
1983-08-30 |
City Of Hope Research Institute |
Solid-phase synthesis of polynucleotides
|
|
US4373071A
(en)
|
1981-04-30 |
1983-02-08 |
City Of Hope Research Institute |
Solid-phase synthesis of polynucleotides
|
|
US4406656A
(en)
|
1981-06-01 |
1983-09-27 |
Brack Gillium Hattler |
Venous catheter having collapsible multi-lumens
|
|
US4475972A
(en)
|
1981-10-01 |
1984-10-09 |
Ontario Research Foundation |
Implantable material
|
|
US4401472A
(en)
|
1982-02-26 |
1983-08-30 |
Martin Marietta Corporation |
Hydraulic cement mixes and processes for improving hydraulic cement mixes
|
|
US4568329A
(en)
|
1982-03-08 |
1986-02-04 |
Mahurkar Sakharam D |
Double lumen catheter
|
|
US4546499A
(en)
|
1982-12-13 |
1985-10-15 |
Possis Medical, Inc. |
Method of supplying blood to blood receiving vessels
|
|
US4530113A
(en)
|
1983-05-20 |
1985-07-23 |
Intervascular, Inc. |
Vascular grafts with cross-weave patterns
|
|
US4647416A
(en)
|
1983-08-03 |
1987-03-03 |
Shiley Incorporated |
Method of preparing a vascular graft prosthesis
|
|
US4550447A
(en)
|
1983-08-03 |
1985-11-05 |
Shiley Incorporated |
Vascular graft prosthesis
|
|
US5104399A
(en)
|
1986-12-10 |
1992-04-14 |
Endovascular Technologies, Inc. |
Artificial graft and implantation method
|
|
US4710169A
(en)
|
1983-12-16 |
1987-12-01 |
Christopher T Graham |
Urinary catheter with collapsible urethral tube
|
|
US4571241A
(en)
|
1983-12-16 |
1986-02-18 |
Christopher T Graham |
Urinary catheter with collapsible urethral tube
|
|
US4737518A
(en)
|
1984-04-03 |
1988-04-12 |
Takeda Chemical Industries, Ltd. |
Lipid derivatives, their production and use
|
|
US4562596A
(en)
|
1984-04-25 |
1986-01-07 |
Elliot Kornberg |
Aortic graft, device and method for performing an intraluminal abdominal aortic aneurysm repair
|
|
US4782836A
(en)
|
1984-05-24 |
1988-11-08 |
Intermedics, Inc. |
Rate adaptive cardiac pacemaker responsive to patient activity and temperature
|
|
US4897355A
(en)
|
1985-01-07 |
1990-01-30 |
Syntex (U.S.A.) Inc. |
N[ω,(ω-1)-dialkyloxy]- and N-[ω,(ω-1)-dialkenyloxy]-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor
|
|
US4662382A
(en)
|
1985-01-16 |
1987-05-05 |
Intermedics, Inc. |
Pacemaker lead with enhanced sensitivity
|
|
US4762915A
(en)
|
1985-01-18 |
1988-08-09 |
Liposome Technology, Inc. |
Protein-liposome conjugates
|
|
US4860751A
(en)
|
1985-02-04 |
1989-08-29 |
Cordis Corporation |
Activity sensor for pacemaker control
|
|
US5223263A
(en)
|
1988-07-07 |
1993-06-29 |
Vical, Inc. |
Liponucleotide-containing liposomes
|
|
CA1320724C
(en)
|
1985-07-19 |
1993-07-27 |
Koichi Kanehira |
Terpene amino alcohols and medicinal uses thereof
|
|
US4701162A
(en)
|
1985-09-24 |
1987-10-20 |
The Kendall Company |
Foley catheter assembly
|
|
US4737323A
(en)
|
1986-02-13 |
1988-04-12 |
Liposome Technology, Inc. |
Liposome extrusion method
|
|
US5153319A
(en)
|
1986-03-31 |
1992-10-06 |
University Patents, Inc. |
Process for preparing polynucleotides
|
|
DE3616824A1
(de)
|
1986-05-17 |
1987-11-19 |
Schering Ag |
Verwendung von haertbaren kunstharzmischungen fuer oberflaechenbeschichtungen und druckfarben und verfahren zu ihrer herstellung
|
|
DE3780374D1
(de)
|
1986-07-31 |
1992-08-20 |
Irnich Werner |
Frequenzadaptierender herzschrittmacher.
|
|
US4960409A
(en)
|
1986-09-11 |
1990-10-02 |
Catalano Marc L |
Method of using bilumen peripheral venous catheter with adapter
|
|
JPH0829776B2
(ja)
|
1986-10-29 |
1996-03-27 |
東燃化学株式会社 |
合成樹脂製容器及びその製造用金型
|
|
US4720517A
(en)
|
1986-11-24 |
1988-01-19 |
Ciba-Geigy Corporation |
Compositions stabilized with N-hydroxyiminodiacetic and dipropionic acids and esters thereof
|
|
US4920016A
(en)
|
1986-12-24 |
1990-04-24 |
Linear Technology, Inc. |
Liposomes with enhanced circulation time
|
|
DE3728917A1
(de)
|
1987-08-29 |
1989-03-09 |
Roth Hermann J |
Neue lipide mit unsymmetrisch substituierter disulfidbruecke
|
|
US4946683A
(en)
|
1987-11-18 |
1990-08-07 |
Vestar, Inc. |
Multiple step entrapment/loading procedure for preparing lipophilic drug-containing liposomes
|
|
US4843155A
(en)
*
|
1987-11-19 |
1989-06-27 |
Piotr Chomczynski |
Product and process for isolating RNA
|
|
US5047540A
(en)
|
1987-12-17 |
1991-09-10 |
Shionogi & Co., Ltd. |
Lipid derivatives
|
|
US5138067A
(en)
|
1987-12-17 |
1992-08-11 |
Shionogi & Co. Ltd. |
Lipid derivatives
|
|
US4892540A
(en)
|
1988-04-21 |
1990-01-09 |
Sorin Biomedica S.P.A. |
Two-leaflet prosthetic heart valve
|
|
US5176661A
(en)
|
1988-09-06 |
1993-01-05 |
Advanced Cardiovascular Systems, Inc. |
Composite vascular catheter
|
|
US5024671A
(en)
|
1988-09-19 |
1991-06-18 |
Baxter International Inc. |
Microporous vascular graft
|
|
US5200395A
(en)
|
1988-10-18 |
1993-04-06 |
Ajinomoto Company, Inc. |
Pharmaceutical composition of BUF-5 for treating anemia
|
|
CA2001401A1
(en)
|
1988-10-25 |
1990-04-25 |
Claude Piantadosi |
Quaternary amine containing ether or ester lipid derivatives and therapeutic compositions
|
|
US5047524A
(en)
|
1988-12-21 |
1991-09-10 |
Applied Biosystems, Inc. |
Automated system for polynucleotide synthesis and purification
|
|
US5262530A
(en)
|
1988-12-21 |
1993-11-16 |
Applied Biosystems, Inc. |
Automated system for polynucleotide synthesis and purification
|
|
US6214804B1
(en)
|
1989-03-21 |
2001-04-10 |
Vical Incorporated |
Induction of a protective immune response in a mammal by injecting a DNA sequence
|
|
US5703055A
(en)
|
1989-03-21 |
1997-12-30 |
Wisconsin Alumni Research Foundation |
Generation of antibodies through lipid mediated DNA delivery
|
|
FR2645866B1
(fr)
|
1989-04-17 |
1991-07-05 |
Centre Nat Rech Scient |
Nouvelles lipopolyamines, leur preparation et leur emploi
|
|
US5194654A
(en)
|
1989-11-22 |
1993-03-16 |
Vical, Inc. |
Lipid derivatives of phosphonoacids for liposomal incorporation and method of use
|
|
US20070053879A1
(en)
*
|
1990-03-05 |
2007-03-08 |
Genzyme Corporation |
Diagnostic and treatment methods involving the cystic fibrosis transmembrane regulator
|
|
US5670488A
(en)
*
|
1992-12-03 |
1997-09-23 |
Genzyme Corporation |
Adenovirus vector for gene therapy
|
|
US5279833A
(en)
|
1990-04-04 |
1994-01-18 |
Yale University |
Liposomal transfection of nucleic acids into animal cells
|
|
US5101824A
(en)
|
1990-04-16 |
1992-04-07 |
Siemens-Pacesetter, Inc. |
Rate-responsive pacemaker with circuitry for processing multiple sensor inputs
|
|
US5264618A
(en)
|
1990-04-19 |
1993-11-23 |
Vical, Inc. |
Cationic lipids for intracellular delivery of biologically active molecules
|
|
WO1992001425A1
(en)
|
1990-07-26 |
1992-02-06 |
Rodney James Lane |
Self expanding vascular endoprosthesis for aneurysms
|
|
US5693338A
(en)
|
1994-09-29 |
1997-12-02 |
Emisphere Technologies, Inc. |
Diketopiperazine-based delivery systems
|
|
JPH0765267B2
(ja)
|
1990-08-22 |
1995-07-12 |
花王株式会社 |
柔軟仕上剤
|
|
US5256294A
(en)
|
1990-09-17 |
1993-10-26 |
Genentech, Inc. |
Tangential flow filtration process and apparatus
|
|
DE69118083T2
(de)
|
1990-10-09 |
1996-08-22 |
Cook Inc |
Perkutane Stentanordnung
|
|
ATE120971T1
(de)
|
1990-12-19 |
1995-04-15 |
Osypka Peter |
Herzschrittmacherleitung mit einem inneren kanal und mit einem elektrodenkopf.
|
|
US5116360A
(en)
|
1990-12-27 |
1992-05-26 |
Corvita Corporation |
Mesh composite graft
|
|
US5405363A
(en)
|
1991-03-15 |
1995-04-11 |
Angelon Corporation |
Implantable cardioverter defibrillator having a smaller displacement volume
|
|
US5330768A
(en)
|
1991-07-05 |
1994-07-19 |
Massachusetts Institute Of Technology |
Controlled drug delivery using polymer/pluronic blends
|
|
US5545449A
(en)
|
1991-10-02 |
1996-08-13 |
Weyerhaeuser Company |
Polyether-reinforced fiber-based materials
|
|
US5151105A
(en)
|
1991-10-07 |
1992-09-29 |
Kwan Gett Clifford |
Collapsible vessel sleeve implant
|
|
US5284491A
(en)
|
1992-02-27 |
1994-02-08 |
Medtronic, Inc. |
Cardiac pacemaker with hysteresis behavior
|
|
US5352461A
(en)
|
1992-03-11 |
1994-10-04 |
Pharmaceutical Discovery Corporation |
Self assembling diketopiperazine drug delivery system
|
|
SE9200951D0
(sv)
|
1992-03-27 |
1992-03-27 |
Kabi Pharmacia Ab |
Pharmaceutical composition containing a defined lipid system
|
|
JPH07505634A
(ja)
|
1992-04-06 |
1995-06-22 |
バイオサイト・ダイアグノスティックス・インコーポレイテッド |
新規オピエート誘導体，タンパクおよびポリペプチドオピエート誘導共役体および標識
|
|
US6670178B1
(en)
|
1992-07-10 |
2003-12-30 |
Transkaryotic Therapies, Inc. |
In Vivo production and delivery of insulinotropin for gene therapy
|
|
KR950702628A
(ko)
|
1992-08-01 |
1995-07-29 |
치세이 라 |
항알레르기 조성물(Antiallergic agent)
|
|
US5334761A
(en)
|
1992-08-28 |
1994-08-02 |
Life Technologies, Inc. |
Cationic lipids
|
|
US5461223A
(en)
|
1992-10-09 |
1995-10-24 |
Eastman Kodak Company |
Bar code detecting circuitry
|
|
US5300022A
(en)
|
1992-11-12 |
1994-04-05 |
Martin Klapper |
Urinary catheter and bladder irrigation system
|
|
US5496362A
(en)
|
1992-11-24 |
1996-03-05 |
Cardiac Pacemakers, Inc. |
Implantable conformal coil patch electrode with multiple conductive elements for cardioversion and defibrillation
|
|
US5552155A
(en)
|
1992-12-04 |
1996-09-03 |
The Liposome Company, Inc. |
Fusogenic lipsomes and methods for making and using same
|
|
US5716395A
(en)
|
1992-12-11 |
1998-02-10 |
W.L. Gore & Associates, Inc. |
Prosthetic vascular graft
|
|
WO1994018987A1
(en)
|
1993-02-19 |
1994-09-01 |
Nippon Shinyaku Co., Ltd. |
Drug composition containing nucleic acid copolymer
|
|
US5395619A
(en)
|
1993-03-03 |
1995-03-07 |
Liposome Technology, Inc. |
Lipid-polymer conjugates and liposomes
|
|
US5697953A
(en)
|
1993-03-13 |
1997-12-16 |
Angeion Corporation |
Implantable cardioverter defibrillator having a smaller displacement volume
|
|
US5624976A
(en)
|
1994-03-25 |
1997-04-29 |
Dentsply Gmbh |
Dental filling composition and method
|
|
US5314430A
(en)
|
1993-06-24 |
1994-05-24 |
Medtronic, Inc. |
Atrial defibrillator employing transvenous and subcutaneous electrodes and method of use
|
|
DE4325848A1
(de)
|
1993-07-31 |
1995-02-02 |
Basf Ag |
Verfahren zur Herstellung von N-(2-Hydroxyethyl)-piperazin
|
|
EP1062999A3
(en)
|
1993-10-06 |
2001-03-14 |
The Kansai Electric Power Co., Inc. |
Method for removing carbon dioxide from combustion exhaust gas
|
|
US5609624A
(en)
|
1993-10-08 |
1997-03-11 |
Impra, Inc. |
Reinforced vascular graft and method of making same
|
|
SE9303481L
(sv)
|
1993-10-22 |
1995-04-23 |
Berol Nobel Ab |
Hygienkomposition
|
|
AU1091095A
(en)
|
1993-11-08 |
1995-05-29 |
Harrison M. Lazarus |
Intraluminal vascular graft and method
|
|
KR960705798A
(ko)
|
1993-11-24 |
1996-11-08 |
벤자민 에프 맥그로우 |
피페라진의 양쪽친화성 유도체(amphiphilic derivatives of piperazine)
|
|
US5595756A
(en)
|
1993-12-22 |
1997-01-21 |
Inex Pharmaceuticals Corporation |
Liposomal compositions for enhanced retention of bioactive agents
|
|
US5464924A
(en)
|
1994-01-07 |
1995-11-07 |
The Dow Chemical Company |
Flexible poly(amino ethers) for barrier packaging
|
|
US5844107A
(en)
|
1994-03-23 |
1998-12-01 |
Case Western Reserve University |
Compacted nucleic acids and their delivery to cells
|
|
EP0758883B1
(en)
|
1994-04-12 |
2003-03-19 |
The Liposome Company, Inc. |
Fusogenic liposomes and methods of making and using same
|
|
US5858747A
(en)
|
1994-07-20 |
1999-01-12 |
Cytotherapeutics, Inc. |
Control of cell growth in a bioartificial organ with extracellular matrix coated microcarriers
|
|
US5820873A
(en)
|
1994-09-30 |
1998-10-13 |
The University Of British Columbia |
Polyethylene glycol modified ceramide lipids and liposome uses thereof
|
|
US5885613A
(en)
|
1994-09-30 |
1999-03-23 |
The University Of British Columbia |
Bilayer stabilizing components and their use in forming programmable fusogenic liposomes
|
|
US5641665A
(en)
|
1994-11-28 |
1997-06-24 |
Vical Incorporated |
Plasmids suitable for IL-2 expression
|
|
US6071890A
(en)
|
1994-12-09 |
2000-06-06 |
Genzyme Corporation |
Organ-specific targeting of cationic amphiphile/DNA complexes for gene therapy
|
|
US5965434A
(en)
|
1994-12-29 |
1999-10-12 |
Wolff; Jon A. |
Amphipathic PH sensitive compounds and delivery systems for delivering biologically active compounds
|
|
US6485726B1
(en)
|
1995-01-17 |
2002-11-26 |
The Brigham And Women's Hospital, Inc. |
Receptor specific transepithelial transport of therapeutics
|
|
US5830430A
(en)
|
1995-02-21 |
1998-11-03 |
Imarx Pharmaceutical Corp. |
Cationic lipids and the use thereof
|
|
JP2001523215A
(ja)
|
1995-04-17 |
2001-11-20 |
イマークス ファーマシューティカル コーポレーション |
ハイブリッド磁気共鳴造影剤
|
|
US20010047091A1
(en)
|
1998-09-09 |
2001-11-29 |
Brian Miki |
Cryptic regulatory elements obtained from plants
|
|
US5772694A
(en)
|
1995-05-16 |
1998-06-30 |
Medical Carbon Research Institute L.L.C. |
Prosthetic heart valve with improved blood flow
|
|
US5700642A
(en)
|
1995-05-22 |
1997-12-23 |
Sri International |
Oligonucleotide sizing using immobilized cleavable primers
|
|
US5783383A
(en)
|
1995-05-23 |
1998-07-21 |
The Board Of Trustees Of The Leland Stanford Junior University |
Method of detecting cytomegalovirus (CMV)
|
|
US5981501A
(en)
|
1995-06-07 |
1999-11-09 |
Inex Pharmaceuticals Corp. |
Methods for encapsulating plasmids in lipid bilayers
|
|
DE69634084T2
(de)
|
1995-06-07 |
2005-12-08 |
Inex Pharmaceuticals Corp. |
Herstellung von lipid-nukleinsäure partikeln duch ein hydrophobische lipid-nukleinsäuree komplexe zwischenprodukt und zur verwendung in der gentransfer
|
|
US7422902B1
(en)
|
1995-06-07 |
2008-09-09 |
The University Of British Columbia |
Lipid-nucleic acid particles prepared via a hydrophobic lipid-nucleic acid complex intermediate and use for gene transfer
|
|
US5705385A
(en)
|
1995-06-07 |
1998-01-06 |
Inex Pharmaceuticals Corporation |
Lipid-nucleic acid particles prepared via a hydrophobic lipid-nucleic acid complex intermediate and use for gene transfer
|
|
US5609629A
(en)
|
1995-06-07 |
1997-03-11 |
Med Institute, Inc. |
Coated implantable medical device
|
|
US5607385A
(en)
|
1995-08-17 |
1997-03-04 |
Medtronic, Inc. |
Device and algorithm for a combined cardiomyostimulator and a cardiac pacer-carioverter-defibrillator
|
|
US5744335A
(en)
|
1995-09-19 |
1998-04-28 |
Mirus Corporation |
Process of transfecting a cell with a polynucleotide mixed with an amphipathic compound and a DNA-binding protein
|
|
FR2740978B1
(fr)
|
1995-11-10 |
1998-01-02 |
Ela Medical Sa |
Dispositif medical actif du type defibrillateur/cardioverteur implantable
|
|
US5874105A
(en)
|
1996-01-31 |
1999-02-23 |
Collaborative Laboratories, Inc. |
Lipid vesicles formed with alkylammonium fatty acid salts
|
|
AU2284697A
(en)
|
1996-04-11 |
1997-10-29 |
University Of British Columbia, The |
Fusogenic liposomes
|
|
US5935936A
(en)
|
1996-06-03 |
1999-08-10 |
Genzyme Corporation |
Compositions comprising cationic amphiphiles and co-lipids for intracellular delivery of therapeutic molecules
|
|
US5913848A
(en)
|
1996-06-06 |
1999-06-22 |
Luther Medical Products, Inc. |
Hard tip over-the-needle catheter and method of manufacturing the same
|
|
US5677124A
(en)
|
1996-07-03 |
1997-10-14 |
Ambion, Inc. |
Ribonuclease resistant viral RNA standards
|
|
US5736573A
(en)
|
1996-07-31 |
1998-04-07 |
Galat; Alexander |
Lipid and water soluble derivatives of drugs
|
|
US6011148A
(en)
*
|
1996-08-01 |
2000-01-04 |
Megabios Corporation |
Methods for purifying nucleic acids
|
|
US7288266B2
(en)
|
1996-08-19 |
2007-10-30 |
United States Of America As Represented By The Secretary, Department Of Health And Human Services |
Liposome complexes for increased systemic delivery
|
|
WO1998008489A1
(en)
|
1996-08-26 |
1998-03-05 |
Transgene S.A. |
Cationic lipid-nucleic acid complexes
|
|
EP1254657B1
(en)
|
1996-09-13 |
2008-05-21 |
Lipoxen Technologies Limited |
Liposomes
|
|
US5874268A
(en)
*
|
1996-09-23 |
1999-02-23 |
Duke University |
Method of introducing exogenous compounds into cells by electroporation and apparatus for same
|
|
TW520297B
(en)
|
1996-10-11 |
2003-02-11 |
Sequus Pharm Inc |
Fusogenic liposome composition and method
|
|
AU738384B2
(en)
|
1996-11-04 |
2001-09-20 |
Qiagen Gmbh |
Cationic reagents for transfection
|
|
US6887665B2
(en)
|
1996-11-14 |
2005-05-03 |
Affymetrix, Inc. |
Methods of array synthesis
|
|
US5985930A
(en)
|
1996-11-21 |
1999-11-16 |
Pasinetti; Giulio M. |
Treatment of neurodegenerative conditions with nimesulide
|
|
US6204297B1
(en)
|
1996-11-26 |
2001-03-20 |
Rhodia Inc. |
Nonionic gemini surfactants
|
|
JPH10197978A
(ja)
|
1997-01-09 |
1998-07-31 |
Mitsubishi Paper Mills Ltd |
ハロゲン化銀写真感光材料
|
|
EP0853123A1
(de)
*
|
1997-01-10 |
1998-07-15 |
Roche Diagnostics GmbH |
Reinigung von DNA durch Cross-Flow-Filtration
|
|
FR2760193B1
(fr)
|
1997-02-28 |
1999-05-28 |
Transgene Sa |
Lipides et complexes de lipides cationiques et de substances actives, notamment pour la transfection de cellules
|
|
US5837283A
(en)
|
1997-03-12 |
1998-11-17 |
The Regents Of The University Of California |
Cationic lipid compositions targeting angiogenic endothelial cells
|
|
US5945326A
(en)
|
1997-03-20 |
1999-08-31 |
New England Biolabs, Inc. |
Method for cloning and producing the Spel restriction endonuclease
|
|
JP4656675B2
(ja)
|
1997-05-14 |
2011-03-23 |
ユニバーシティー オブ ブリティッシュ コロンビア |
脂質小胞への荷電した治療剤の高率封入
|
|
US20030104044A1
(en)
|
1997-05-14 |
2003-06-05 |
Semple Sean C. |
Compositions for stimulating cytokine secretion and inducing an immune response
|
|
US6835395B1
(en)
|
1997-05-14 |
2004-12-28 |
The University Of British Columbia |
Composition containing small multilamellar oligodeoxynucleotide-containing lipid vesicles
|
|
JPH115786A
(ja)
|
1997-06-13 |
1999-01-12 |
Pola Chem Ind Inc |
新規アミノヒドロキシプロピルピペラジン誘導体
|
|
US6067471A
(en)
|
1998-08-07 |
2000-05-23 |
Cardiac Pacemakers, Inc. |
Atrial and ventricular implantable cardioverter-defibrillator and lead system
|
|
JPH1180142A
(ja)
|
1997-09-05 |
1999-03-26 |
Pola Chem Ind Inc |
ジフェニルアルキル化合物の製造法
|
|
US20030083272A1
(en)
|
1997-09-19 |
2003-05-01 |
Lahive & Cockfield, Llp |
Sense mrna therapy
|
|
US6165763A
(en)
|
1997-10-30 |
2000-12-26 |
Smithkline Beecham Corporation |
Ornithine carbamoyltransferase
|
|
US6096075A
(en)
|
1998-01-22 |
2000-08-01 |
Medical Carbon Research Institute, Llc |
Prosthetic heart valve
|
|
US6617171B2
(en)
|
1998-02-27 |
2003-09-09 |
The General Hospital Corporation |
Methods for diagnosing and treating autoimmune disease
|
|
US6271209B1
(en)
|
1998-04-03 |
2001-08-07 |
Valentis, Inc. |
Cationic lipid formulation delivering nucleic acid to peritoneal tumors
|
|
US6176877B1
(en)
|
1998-04-20 |
2001-01-23 |
St. Jude Medical, Inc. |
Two piece prosthetic heart valve
|
|
US6986902B1
(en)
|
1998-04-28 |
2006-01-17 |
Inex Pharmaceuticals Corporation |
Polyanionic polymers which enhance fusogenicity
|
|
DE19822602A1
(de)
|
1998-05-20 |
1999-11-25 |
Goldschmidt Ag Th |
Verfahren zur Herstellung von Polyaminosäureestern durch Veresterung von sauren Polyaminosäuren oder Umesterung von Polyaminosäureestern
|
|
NO313244B1
(no)
|
1998-07-08 |
2002-09-02 |
Crew Dev Corp |
Fremgangsmåte for isolering og produksjon av magnesitt eller magnesiumklorid
|
|
US6055454A
(en)
|
1998-07-27 |
2000-04-25 |
Cardiac Pacemakers, Inc. |
Cardiac pacemaker with automatic response optimization of a physiologic sensor based on a second sensor
|
|
US6299604B1
(en)
|
1998-08-20 |
2001-10-09 |
Cook Incorporated |
Coated implantable medical device
|
|
US6210892B1
(en)
|
1998-10-07 |
2001-04-03 |
Isis Pharmaceuticals, Inc. |
Alteration of cellular behavior by antisense modulation of mRNA processing
|
|
WO2000030444A1
(en)
|
1998-11-25 |
2000-06-02 |
Vanderbilt University |
Cationic liposomes for gene transfer
|
|
US6740643B2
(en)
*
|
1999-01-21 |
2004-05-25 |
Mirus Corporation |
Compositions and methods for drug delivery using amphiphile binding molecules
|
|
US6248725B1
(en)
|
1999-02-23 |
2001-06-19 |
Amgen, Inc. |
Combinations and methods for promoting in vivo liver cell proliferation and enhancing in vivo liver-directed gene transduction
|
|
US6379698B1
(en)
|
1999-04-06 |
2002-04-30 |
Isis Pharmaceuticals, Inc. |
Fusogenic lipids and vesicles
|
|
CA2370690A1
(en)
|
1999-04-20 |
2000-10-26 |
The University Of British Columbia |
Cationic peg-lipids and methods of use
|
|
US6169923B1
(en)
|
1999-04-23 |
2001-01-02 |
Pacesetter, Inc. |
Implantable cardioverter-defibrillator with automatic arrhythmia detection criteria adjustment
|
|
AU769425B2
(en)
|
1999-04-23 |
2004-01-29 |
Alza Corporation |
Conjugate having a cleavable linkage for use in a liposome
|
|
MXPA01011845A
(es)
|
1999-05-19 |
2002-06-21 |
Lexigen Pharm Corp |
Expresion y exportacion de proteinas de interferon-alfa como proteinas de fusion fc.
|
|
US6696424B1
(en)
|
1999-05-28 |
2004-02-24 |
Vical Incorporated |
Cytofectin dimers and methods of use thereof
|
|
US6346382B1
(en)
|
1999-06-01 |
2002-02-12 |
Vanderbilt University |
Human carbamyl phosphate synthetase I polymorphism and diagnostic methods related thereto
|
|
WO2001005375A1
(en)
|
1999-07-16 |
2001-01-25 |
Purdue Research Foundation |
Vinyl ether lipids with cleavable hydrophilic headgroups
|
|
JP2003505077A
(ja)
*
|
1999-07-23 |
2003-02-12 |
ジェネンテック・インコーポレーテッド |
平行流ろ過法を用いるｒｎａｓｅ−及び有機溶媒−非含有プラスミドｄｎａの精製方法
|
|
US6358278B1
(en)
|
1999-09-24 |
2002-03-19 |
St. Jude Medical, Inc. |
Heart valve prosthesis with rotatable cuff
|
|
US6371983B1
(en)
|
1999-10-04 |
2002-04-16 |
Ernest Lane |
Bioprosthetic heart valve
|
|
US7060291B1
(en)
|
1999-11-24 |
2006-06-13 |
Transave, Inc. |
Modular targeted liposomal delivery system
|
|
CN1433478A
(zh)
|
1999-12-30 |
2003-07-30 |
诺瓦提斯公司 |
用于基因治疗的新的胶体合成载体
|
|
US20010036454A1
(en)
|
2000-02-17 |
2001-11-01 |
Chester Li |
Genetic modification of the lung as a portal for gene delivery
|
|
US6370434B1
(en)
|
2000-02-28 |
2002-04-09 |
Cardiac Pacemakers, Inc. |
Cardiac lead and method for lead implantation
|
|
IL152527A0
(en)
*
|
2000-05-12 |
2003-05-29 |
Univ Southern California |
Retroviral vectors comprising an enhanced 3'transcription termination structure
|
|
US6565960B2
(en)
|
2000-06-01 |
2003-05-20 |
Shriners Hospital Of Children |
Polymer composite compositions
|
|
IL138474A0
(en)
|
2000-09-14 |
2001-10-31 |
Epox Ltd |
Highly branched water-soluble polyamine oligomers, process for their preparation and applications thereof
|
|
USRE43612E1
(en)
|
2000-10-10 |
2012-08-28 |
Massachusetts Institute Of Technology |
Biodegradable poly(β-amino esters) and uses thereof
|
|
US7427394B2
(en)
|
2000-10-10 |
2008-09-23 |
Massachusetts Institute Of Technology |
Biodegradable poly(β-amino esters) and uses thereof
|
|
US6998115B2
(en)
|
2000-10-10 |
2006-02-14 |
Massachusetts Institute Of Technology |
Biodegradable poly(β-amino esters) and uses thereof
|
|
US7202226B2
(en)
*
|
2000-10-23 |
2007-04-10 |
Detroit R & D |
Augmentation of wound healing by elF-4E mRNA and EGF mRNA
|
|
WO2002034236A2
(en)
|
2000-10-25 |
2002-05-02 |
The University Of British Columbia |
Lipid formulations for target delivery
|
|
GB0028361D0
(en)
*
|
2000-11-21 |
2001-01-03 |
Glaxo Group Ltd |
Method of separating extra chromosomal dna from other cellular components
|
|
US20020094528A1
(en)
|
2000-11-29 |
2002-07-18 |
Salafsky Joshua S. |
Method and apparatus using a surface-selective nonlinear optical technique for detection of probe-target interations
|
|
JP2002167368A
(ja)
|
2000-12-01 |
2002-06-11 |
Nitto Denko Corp |
アルキル置換デンドリマーおよびその製造法
|
|
US20050004058A1
(en)
|
2000-12-07 |
2005-01-06 |
Patrick Benoit |
Sequences upstream of the carp gene, vectors containing them and uses thereof
|
|
JP2004527236A
(ja)
|
2001-02-14 |
2004-09-09 |
ベイラー カレッジ オブ メディスン |
Ｒｎａ増幅の方法及び組成物
|
|
DE10109897A1
(de)
|
2001-02-21 |
2002-11-07 |
Novosom Ag |
Fakultativ kationische Liposomen und Verwendung dieser
|
|
US20020192721A1
(en)
|
2001-03-28 |
2002-12-19 |
Engeneos, Inc. |
Modular molecular clasps and uses thereof
|
|
TW588032B
(en)
|
2001-04-23 |
2004-05-21 |
Shinetsu Chemical Co |
New tertiary amine compound having ester structure and method for producing the same
|
|
US6585410B1
(en)
|
2001-05-03 |
2003-07-01 |
The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration |
Radiant temperature nulling radiometer
|
|
CA2830887C
(en)
|
2001-06-05 |
2016-11-29 |
Curevac Gmbh |
Pharmaceutical composition containing a stabilised mrna optimised for translation in its coding regions
|
|
JP4371812B2
(ja)
|
2001-09-28 |
2009-11-25 |
マックス−プランク−ゲゼルシャフト・ツア・フェルデルング・デア・ヴィッセンシャフテン・エー・ファオ |
マイクロｒｎａ分子
|
|
JP3979996B2
(ja)
*
|
2001-10-12 |
2007-09-19 |
ジェントラ システムズ インコーポレイテッド |
固体支持体を使用してｒｎａを精製するための組成物および方法
|
|
AU2002340490A1
(en)
|
2001-11-09 |
2003-05-19 |
Bayer Healthcare Ag |
Isotopically coded affinity markers 3
|
|
DE10162480A1
(de)
|
2001-12-19 |
2003-08-07 |
Ingmar Hoerr |
Die Applikation von mRNA für den Einsatz als Therapeutikum gegen Tumorerkrankungen
|
|
DE10207178A1
(de)
|
2002-02-19 |
2003-09-04 |
Novosom Ag |
Komponenten für die Herstellung amphoterer Liposomen
|
|
AU2003220249A1
(en)
*
|
2002-03-15 |
2003-09-29 |
Arcturus Bioscience, Inc. |
Improved nucleic acid amplification
|
|
DE10214983A1
(de)
|
2002-04-04 |
2004-04-08 |
TransMIT Gesellschaft für Technologietransfer mbH |
Vernebelbare Liposomen und ihre Verwendung zur pulmonalen Applikation von Wirkstoffen
|
|
GB0208390D0
(en)
|
2002-04-11 |
2002-05-22 |
Univ London |
Adeno-associated virus producer system
|
|
US20030215395A1
(en)
|
2002-05-14 |
2003-11-20 |
Lei Yu |
Controllably degradable polymeric biomolecule or drug carrier and method of synthesizing said carrier
|
|
US7601367B2
(en)
|
2002-05-28 |
2009-10-13 |
Mirus Bio Llc |
Compositions and processes using siRNA, amphipathic compounds and polycations
|
|
DE60334618D1
(de)
|
2002-06-28 |
2010-12-02 |
Protiva Biotherapeutics Inc |
Verfahren und vorrichtung zur herstellung von liposomen
|
|
DE10229872A1
(de)
|
2002-07-03 |
2004-01-29 |
Curevac Gmbh |
Immunstimulation durch chemisch modifizierte RNA
|
|
US20040028804A1
(en)
|
2002-08-07 |
2004-02-12 |
Anderson Daniel G. |
Production of polymeric microarrays
|
|
US20050244961A1
(en)
|
2002-08-22 |
2005-11-03 |
Robert Short |
Cell culture surface
|
|
US20060160759A1
(en)
*
|
2002-09-28 |
2006-07-20 |
Jianzhu Chen |
Influenza therapeutic
|
|
MXPA05004762A
(es)
|
2002-11-04 |
2005-08-03 |
Ge Bayer Silicones Gmbh & Co |
Copolimeros de poliamino y/o poliamonio polisiloxano i lineales.
|
|
AU2003281978A1
(en)
|
2002-11-22 |
2004-06-18 |
Boehringer Ingelheim International Gmbh |
2,5-diketopiperazines for the treatment of obesity
|
|
US7169892B2
(en)
|
2003-01-10 |
2007-01-30 |
Astellas Pharma Inc. |
Lipid-peptide-polymer conjugates for long blood circulation and tumor specific drug delivery systems
|
|
KR100774067B1
(ko)
|
2003-01-20 |
2007-11-06 |
아사히 가세이 일렉트로닉스 가부시끼가이샤 |
포인팅 디바이스
|
|
EP1601767B1
(en)
|
2003-03-05 |
2012-04-25 |
Senesco Technologies, Inc. |
USE OF siRNA TO SUPPRESS EXPRESSION OF EIF-5A1 IN THE TREATMENT OF GLAUCOMA
|
|
US20040224912A1
(en)
|
2003-05-07 |
2004-11-11 |
Isis Pharmaceuticals Inc. |
Modulation of PAI-1 mRNA-binding protein expression
|
|
US7619017B2
(en)
|
2003-05-19 |
2009-11-17 |
Wacker Chemical Corporation |
Polymer emulsions resistant to biodeterioration
|
|
WO2005007810A2
(en)
|
2003-06-16 |
2005-01-27 |
Grinstaff Mark W |
Functional synthetic molecules and macromolecules for gene delivery
|
|
US20050059024A1
(en)
|
2003-07-25 |
2005-03-17 |
Ambion, Inc. |
Methods and compositions for isolating small RNA molecules
|
|
JP4842821B2
(ja)
|
2003-09-15 |
2011-12-21 |
プロチバ バイオセラピューティクス インコーポレイティッド |
ポリエチレングリコール修飾脂質化合物およびその使用
|
|
EP1675943A4
(en)
|
2003-09-15 |
2007-12-05 |
Massachusetts Inst Technology |
NANOLITRE SYNTHESIS OF BIOMATERIALS IN NETWORKS AND SCREENING THEREOF
|
|
US20050069590A1
(en)
|
2003-09-30 |
2005-03-31 |
Buehler Gail K. |
Stable suspensions for medicinal dosages
|
|
NZ546554A
(en)
|
2003-10-10 |
2009-04-30 |
Powderject Vaccines Inc |
Nucleic acid constructs
|
|
WO2005037226A2
(en)
|
2003-10-17 |
2005-04-28 |
Georgia Tech Research Corporation |
Genetically engineered enteroendocrine cells for treating glucose-related metabolic disorders
|
|
AU2004287652A1
(en)
|
2003-11-10 |
2005-05-19 |
Nippon Kayaku Kabushiki Kaisha |
Diimonium salt compound and use thereof
|
|
US8075780B2
(en)
*
|
2003-11-24 |
2011-12-13 |
Millipore Corporation |
Purification and concentration of synthetic biological molecules
|
|
US7115719B2
(en)
*
|
2003-12-16 |
2006-10-03 |
Gentra Systems, Inc. |
Formulations and methods for denaturing proteins
|
|
US7022214B2
(en)
|
2004-01-21 |
2006-04-04 |
Bio-Rad Laboratories, Inc. |
Carrier ampholytes of high pH range
|
|
US7556684B2
(en)
|
2004-02-26 |
2009-07-07 |
Construction Research & Technology Gmbh |
Amine containing strength improvement admixture
|
|
US20060228404A1
(en)
|
2004-03-04 |
2006-10-12 |
Anderson Daniel G |
Compositions and methods for treatment of hypertrophic tissues
|
|
JP2006271201A
(ja)
*
|
2004-03-26 |
2006-10-12 |
Fuji Photo Film Co Ltd |
Ｒｎａの選択的分離精製方法
|
|
WO2005093052A1
(en)
|
2004-03-26 |
2005-10-06 |
Fuji Photo Film Co., Ltd. |
Method for selectively separating and purifying rna and method for separating and purifying nucleic acid
|
|
EP1766035B1
(en)
|
2004-06-07 |
2011-12-07 |
Protiva Biotherapeutics Inc. |
Lipid encapsulated interfering rna
|
|
JP4764426B2
(ja)
|
2004-06-07 |
2011-09-07 |
プロチバ バイオセラピューティクス インコーポレイティッド |
カチオン性脂質および使用方法
|
|
US7670595B2
(en)
|
2004-06-28 |
2010-03-02 |
Merck Patent Gmbh |
Fc-interferon-beta fusion proteins
|
|
GB0418172D0
(en)
|
2004-08-13 |
2004-09-15 |
Ic Vec Ltd |
Vector
|
|
US7361465B2
(en)
|
2004-09-07 |
2008-04-22 |
Applera Corporation |
Methods and compositions for tailing and amplifying RNA
|
|
DE102004043342A1
(de)
|
2004-09-08 |
2006-03-09 |
Bayer Materialscience Ag |
Blockierte Polyurethan-Prepolymere als Klebstoffe
|
|
CA2586708A1
(en)
|
2004-11-05 |
2006-05-11 |
Novosom Ag |
Improvements in or relating to pharmaceutical compositions comprising an oligonucleotide as an active agent
|
|
AU2006211216B2
(en)
*
|
2005-01-31 |
2011-02-03 |
Merck Sharp & Dohme Llc |
Purification process for plasmid DNA
|
|
GB0502482D0
(en)
|
2005-02-07 |
2005-03-16 |
Glaxo Group Ltd |
Novel compounds
|
|
AU2006336384B2
(en)
|
2005-02-14 |
2010-12-16 |
Sirna Therapeutics, Inc. |
Lipid nanoparticle based compositions and methods for the delivery of biologically active molecules
|
|
WO2006105043A2
(en)
|
2005-03-28 |
2006-10-05 |
Dendritic Nanotechnologies, Inc. |
Janus dendrimers and dendrons
|
|
US9006487B2
(en)
|
2005-06-15 |
2015-04-14 |
Massachusetts Institute Of Technology |
Amine-containing lipids and uses thereof
|
|
BRPI0614086A2
(pt)
*
|
2005-08-05 |
2011-03-09 |
Pfizer Prod Inc |
fabricação automatizada em batelada
|
|
SI3611266T1
(sl)
|
2005-08-23 |
2023-02-28 |
The Trustees Of The University Of Pennsylvania |
Modificirani nukleozidi, ki vsebujejo RNA, in postopki za njihovo uporabo
|
|
US9012219B2
(en)
|
2005-08-23 |
2015-04-21 |
The Trustees Of The University Of Pennsylvania |
RNA preparations comprising purified modified RNA for reprogramming cells
|
|
WO2007031091A2
(en)
|
2005-09-15 |
2007-03-22 |
Santaris Pharma A/S |
Rna antagonist compounds for the modulation of p21 ras expression
|
|
AU2006308765B2
(en)
|
2005-11-02 |
2013-09-05 |
Arbutus Biopharma Corporation |
Modified siRNA molecules and uses thereof
|
|
US7238791B1
(en)
|
2005-12-16 |
2007-07-03 |
Roche Diagnostics Operations, Inc. |
6-monoacetylmorphine derivatives useful in immunoassay
|
|
WO2007073489A2
(en)
|
2005-12-22 |
2007-06-28 |
Trustees Of Boston University |
Molecules for gene delivery and gene therapy, and methods of use thereof
|
|
CN100569877C
(zh)
|
2005-12-30 |
2009-12-16 |
财团法人工业技术研究院 |
含多uv交联反应基的分枝状结构化合物及其应用
|
|
EP2010659B1
(en)
|
2006-04-14 |
2014-06-18 |
CellScript, Inc. |
Kits and methods for generating 5' capped RNA
|
|
US9085778B2
(en)
|
2006-05-03 |
2015-07-21 |
VL27, Inc. |
Exosome transfer of nucleic acids to cells
|
|
US20070275923A1
(en)
|
2006-05-25 |
2007-11-29 |
Nastech Pharmaceutical Company Inc. |
CATIONIC PEPTIDES FOR siRNA INTRACELLULAR DELIVERY
|
|
EP2032652A4
(en)
|
2006-06-05 |
2011-08-17 |
Massachusetts Inst Technology |
NETWORKED DEVELOPABLE POLYMERS AND ITS USE
|
|
US20080113357A1
(en)
|
2006-06-29 |
2008-05-15 |
Millipore Corporation |
Filter device for the isolation of a nucleic acid
|
|
US20090186805A1
(en)
|
2006-07-06 |
2009-07-23 |
Aaron Thomas Tabor |
Compositions and Methods for Genetic Modification of Cells Having Cosmetic Function to Enhance Cosmetic Appearance
|
|
ES2293834B1
(es)
|
2006-07-20 |
2009-02-16 |
Consejo Superior Investig. Cientificas |
Compuesto con actividad inhibidora de las interacciones ubc13-uev, composiciones farmaceuticas que lo comprenden y sus aplicaciones terapeuticas.
|
|
WO2008011561A2
(en)
|
2006-07-21 |
2008-01-24 |
Massachusetts Institute Of Technology |
End-modified poly(beta-amino esters) and uses thereof
|
|
CA3144493A1
(en)
|
2006-10-03 |
2008-04-10 |
Arbutus Biopharma Corporation |
Lipid containing formulations
|
|
DE102006051516A1
(de)
|
2006-10-31 |
2008-05-08 |
Curevac Gmbh |
(Basen-)modifizierte RNA zur Expressionssteigerung eines Proteins
|
|
WO2008140615A2
(en)
|
2006-12-21 |
2008-11-20 |
Novozymes, Inc. |
Modified messenger rna stabilizing sequences for expressing genes in bacterial cells
|
|
DE102007001370A1
(de)
|
2007-01-09 |
2008-07-10 |
Curevac Gmbh |
RNA-kodierte Antikörper
|
|
EP2125030A2
(en)
|
2007-01-29 |
2009-12-02 |
Medipol S.A. |
Chitosan-based colloidal particles for rna delivery
|
|
WO2008097926A2
(en)
|
2007-02-02 |
2008-08-14 |
Yale University |
Transient transfection with rna
|
|
EP2139461A2
(en)
|
2007-03-20 |
2010-01-06 |
Recepticon Aps |
Amino derivatives to prevent nephrotoxicity and cancer
|
|
JP5186126B2
(ja)
|
2007-03-29 |
2013-04-17 |
公益財団法人地球環境産業技術研究機構 |
新規トリアジン誘導体ならびにその製法およびそのガス分離膜としての用途
|
|
NZ580973A
(en)
|
2007-04-18 |
2011-10-28 |
Cornerstone Pharmaceuticals Inc |
Pharmaceutical formulations containing lipoic acid derivatives
|
|
WO2008137470A1
(en)
|
2007-05-01 |
2008-11-13 |
Pgr-Solutions |
Multi-chain lipophilic polyamines
|
|
US20090163705A1
(en)
|
2007-05-21 |
2009-06-25 |
Alnylam Pharmaceuticals, Inc. |
Cationic lipids
|
|
CN101939027B
(zh)
|
2007-10-02 |
2014-07-30 |
玛瑞纳生物技术有限公司 |
用于递送核酸的脂肽
|
|
CA2930393C
(en)
|
2007-12-04 |
2022-11-29 |
Alnylam Pharmaceuticals, Inc. |
Carbohydrate conjugates as delivery agents for oligonucleotides
|
|
CA2710983A1
(en)
|
2007-12-27 |
2009-10-01 |
The Ohio State University Research Foundation |
Lipid nanoparticle compositions and methods of making and using the same
|
|
AU2008342535B2
(en)
|
2007-12-27 |
2015-02-05 |
Arbutus Biopharma Corporation |
Silencing of polo-like kinase expression using interfering RNA
|
|
US20110097720A1
(en)
|
2008-01-02 |
2011-04-28 |
Alnylam Pharmaceuticals, Inc. |
Screening method for selected amino lipid-containing compositions
|
|
FR2926560A1
(fr)
|
2008-01-21 |
2009-07-24 |
Millipore Corp |
Procede d'extraction et de purification d'acides nucleiques sur membrane
|
|
CA2721183C
(en)
|
2008-04-11 |
2019-07-16 |
Alnylam Pharmaceuticals, Inc. |
Site-specific delivery of nucleic acids by combining targeting ligands with endosomolytic components
|
|
CA2721333C
(en)
|
2008-04-15 |
2020-12-01 |
Protiva Biotherapeutics, Inc. |
Novel lipid formulations for nucleic acid delivery
|
|
WO2009127230A1
(en)
|
2008-04-16 |
2009-10-22 |
Curevac Gmbh |
MODIFIED (m)RNA FOR SUPPRESSING OR AVOIDING AN IMMUNOSTIMULATORY RESPONSE AND IMMUNOSUPPRESSIVE COMPOSITION
|
|
US20090263407A1
(en)
|
2008-04-16 |
2009-10-22 |
Abbott Laboratories |
Cationic Lipids and Uses Thereof
|
|
AU2009256243A1
(en)
|
2008-06-04 |
2009-12-10 |
The Board Of Regents Of The University Of Texas System |
Modulation of gene expression through endogenous small RNA targeting of gene promoters
|
|
US20100012012A1
(en)
|
2008-07-19 |
2010-01-21 |
Mark Schaefbauer |
Positioning apparatus
|
|
JP5024216B2
(ja)
|
2008-07-23 |
2012-09-12 |
トヨタ自動車株式会社 |
内燃機関の点火時期制御装置及び点火時期制御方法
|
|
US20100035249A1
(en)
|
2008-08-05 |
2010-02-11 |
Kabushiki Kaisha Dnaform |
Rna sequencing and analysis using solid support
|
|
JP5492207B2
(ja)
|
2008-08-27 |
2014-05-14 |
ライフ テクノロジーズ コーポレーション |
生物学的サンプルの処理装置および処理方法
|
|
JP2010053108A
(ja)
*
|
2008-08-29 |
2010-03-11 |
Asahi Kasei Corp |
荷電を有する限外濾過膜を用いた生体成分の分離方法およびモジュール、装置
|
|
AU2009303345B2
(en)
|
2008-10-09 |
2015-08-20 |
Arbutus Biopharma Corporation |
Improved amino lipids and methods for the delivery of nucleic acids
|
|
WO2010045512A2
(en)
|
2008-10-16 |
2010-04-22 |
Mdrna , Inc. |
Processes and compositions for liposomal and efficient delivery of gene silencing therapeutics
|
|
US9080211B2
(en)
|
2008-10-24 |
2015-07-14 |
Epicentre Technologies Corporation |
Transposon end compositions and methods for modifying nucleic acids
|
|
US20120009222A1
(en)
|
2008-10-27 |
2012-01-12 |
Massachusetts Institute Of Technology |
Modulation of the immune response
|
|
US8588371B2
(en)
|
2008-11-05 |
2013-11-19 |
Hitachi Medical Corporation |
Phase shift inverter, X-ray high-voltage device using same, X-ray CT device, and X-ray imaging device
|
|
CN104910025B
(zh)
|
2008-11-07 |
2019-07-16 |
麻省理工学院 |
氨基醇类脂质和其用途
|
|
KR102042721B1
(ko)
|
2008-11-10 |
2019-11-11 |
알닐람 파마슈티칼스 인코포레이티드 |
치료제 운반용 신규 지질 및 조성물
|
|
JP2012509258A
(ja)
|
2008-11-17 |
2012-04-19 |
エンゾン ファーマシューティカルズ，インコーポレーテッド |
核酸送達系のための分岐カチオン性脂質
|
|
WO2010066634A1
(en)
|
2008-12-09 |
2010-06-17 |
F. Hoffmann-La Roche Ag |
Method for obtaining an excipient-free antibody solution
|
|
WO2010083615A1
(en)
|
2009-01-26 |
2010-07-29 |
Protiva Biotherapeutics, Inc. |
Compositions and methods for silencing apolipoprotein c-iii expression
|
|
US20100222489A1
(en)
|
2009-02-27 |
2010-09-02 |
Jiang Dayue D |
Copolymer composition, membrane article, and methods thereof
|
|
CA2754043A1
(en)
|
2009-03-12 |
2010-09-16 |
Alnylam Pharmaceuticals, Inc. |
Lipid formulated compositions and methods for inhibiting expression of eg5 and vegf genes
|
|
WO2010114789A1
(en)
|
2009-04-02 |
2010-10-07 |
The Siemon Company |
Telecommunications patch panel
|
|
US20130053426A1
(en)
|
2009-04-17 |
2013-02-28 |
Yiqi Seow |
Composition For Delivery Of Genetic Material
|
|
EP2421563B1
(en)
*
|
2009-04-22 |
2017-04-12 |
Massachusetts Institute of Technology |
Innate immune suppression enables repeated delivery of long rna molecules
|
|
CA3042927C
(en)
|
2009-05-05 |
2022-05-17 |
Arbutus Biopharma Corporation |
Lipid compositions for the delivery of therapeutic agents
|
|
KR20230098713A
(ko)
|
2009-06-10 |
2023-07-04 |
알닐람 파마슈티칼스 인코포레이티드 |
향상된 지질 조성물
|
|
BRPI1010689A2
(pt)
|
2009-06-15 |
2016-03-15 |
Alnylam Pharmaceuticals Inc |
"dsrna formulado por lipídios direcionados para o gene pcsk9"
|
|
WO2010147992A1
(en)
|
2009-06-15 |
2010-12-23 |
Alnylam Pharmaceuticals, Inc. |
Methods for increasing efficacy of lipid formulated sirna
|
|
US8569256B2
(en)
|
2009-07-01 |
2013-10-29 |
Protiva Biotherapeutics, Inc. |
Cationic lipids and methods for the delivery of therapeutic agents
|
|
CA2767129C
(en)
|
2009-07-01 |
2015-01-06 |
Protiva Biotherapeutics, Inc. |
Compositions and methods for silencing apolipoprotein b
|
|
US9018187B2
(en)
|
2009-07-01 |
2015-04-28 |
Protiva Biotherapeutics, Inc. |
Cationic lipids and methods for the delivery of therapeutic agents
|
|
US8716464B2
(en)
|
2009-07-20 |
2014-05-06 |
Thomas W. Geisbert |
Compositions and methods for silencing Ebola virus gene expression
|
|
BR112012002134B8
(pt)
|
2009-07-30 |
2021-05-25 |
Salvat Lab Sa |
compostos inibidores de apaf-1
|
|
CN105255881A
(zh)
|
2009-07-31 |
2016-01-20 |
埃泽瑞斯公司 |
用于蛋白质表达的具有未修饰和修饰核苷酸的组合的rna
|
|
WO2011021666A1
(ja)
|
2009-08-19 |
2011-02-24 |
国立大学法人奈良先端科学技術大学院大学 |
環境ストレス下の翻訳抑制を回避する5'utrをコードする組換えｄｎａ分子
|
|
DE102009043342A1
(de)
|
2009-09-29 |
2011-03-31 |
Bayer Technology Services Gmbh |
Stoffe für selbstorganisierte Träger zur kontrollierten Freisetzung eines Wirkstoffs
|
|
AU2010305768B2
(en)
*
|
2009-10-15 |
2015-05-14 |
Crucell Holland B.V. |
Process for adenovirus purification from high cell density cultures
|
|
PT3338765T
(pt)
|
2009-12-01 |
2019-03-18 |
Translate Bio Inc |
Derivado de esteróide adequado para a administração de arnm em doenças genéticas humanas
|
|
JP2013512690A
(ja)
|
2009-12-07 |
2013-04-18 |
ザ トラスティース オブ ザ ユニバーシティ オブ ペンシルベニア |
細胞を再プログラム化するための精製された修飾ｒｎａを含むｒｎａ調製物
|
|
WO2011075656A1
(en)
|
2009-12-18 |
2011-06-23 |
The University Of British Columbia |
Methods and compositions for delivery of nucleic acids
|
|
SG10201407996PA
(en)
|
2009-12-23 |
2015-01-29 |
Novartis Ag |
Lipids, lipid compositions, and methods of using them
|
|
US9315802B2
(en)
|
2009-12-30 |
2016-04-19 |
Quest Diagnostics Investments Incorporated |
RNA isolation from soluble urine fractions
|
|
CA2799091A1
(en)
|
2010-05-12 |
2011-11-17 |
Protiva Biotherapeutics, Inc. |
Cationic lipids and methods of use thereof
|
|
EP2575764B1
(en)
|
2010-06-03 |
2017-04-19 |
Alnylam Pharmaceuticals, Inc. |
Biodegradable lipids for the delivery of active agents
|
|
CN101863544B
(zh)
|
2010-06-29 |
2011-09-28 |
湖南科技大学 |
一种氰尿酸基重金属螯合絮凝剂及其制备方法
|
|
US9006417B2
(en)
|
2010-06-30 |
2015-04-14 |
Protiva Biotherapeutics, Inc. |
Non-liposomal systems for nucleic acid delivery
|
|
US20130323269A1
(en)
|
2010-07-30 |
2013-12-05 |
Muthiah Manoharan |
Methods and compositions for delivery of active agents
|
|
US8822663B2
(en)
|
2010-08-06 |
2014-09-02 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
|
WO2012019630A1
(en)
|
2010-08-13 |
2012-02-16 |
Curevac Gmbh |
Nucleic acid comprising or coding for a histone stem-loop and a poly(a) sequence or a polyadenylation signal for increasing the expression of an encoded protein
|
|
EP2609135A4
(en)
|
2010-08-26 |
2015-05-20 |
Massachusetts Inst Technology |
POLY (BETA-AMINO ALCOHOLS), THEIR PREPARATION AND USES THEREOF
|
|
WO2012026493A1
(ja)
|
2010-08-26 |
2012-03-01 |
アイシン精機株式会社 |
酵素結晶固定化電極及び酵素結晶固定化電極の製造方法、並びに酵素結晶固定化電極を備えるバイオ電池及びバイオセンサー
|
|
WO2012031294A2
(en)
|
2010-09-03 |
2012-03-08 |
University Of Maryland, College Park |
Methods for determining protein ligand binding
|
|
TWI441591B
(zh)
*
|
2010-09-07 |
2014-06-21 |
Univ Nat Central |
使植物表現後天性高溫逆境耐受性狀的方法及其應用
|
|
CA3162352A1
(en)
|
2010-10-01 |
2012-04-05 |
Modernatx, Inc. |
Modified nucleosides, nucleotides, and nucleic acids, and uses thereof
|
|
WO2012075040A2
(en)
|
2010-11-30 |
2012-06-07 |
Shire Human Genetic Therapies, Inc. |
mRNA FOR USE IN TREATMENT OF HUMAN GENETIC DISEASES
|
|
JP2014506873A
(ja)
*
|
2010-12-10 |
2014-03-20 |
トンプソン トレイシー |
分離方法のための組成物
|
|
PL2691443T3
(pl)
|
2011-03-28 |
2021-08-30 |
Massachusetts Institute Of Technology |
Sprzężone lipomery i ich zastosowania
|
|
WO2012133737A1
(ja)
|
2011-03-31 |
2012-10-04 |
公益財団法人地球環境産業技術研究機構 |
架橋性アミン化合物、該化合物を用いた高分子膜及びその製造方法
|
|
AU2012236099A1
(en)
|
2011-03-31 |
2013-10-03 |
Moderna Therapeutics, Inc. |
Delivery and formulation of engineered nucleic acids
|
|
US11767534B2
(en)
|
2011-05-04 |
2023-09-26 |
The Broad Institute, Inc. |
Multiplexed genetic reporter assays and compositions
|
|
WO2012158736A1
(en)
|
2011-05-17 |
2012-11-22 |
modeRNA Therapeutics |
Engineered nucleic acids and methods of use thereof for non-human vertebrates
|
|
EP2532649B1
(en)
|
2011-06-07 |
2015-04-08 |
Incella GmbH |
Amino lipids, their synthesis and uses thereof
|
|
BR112013031553A2
(pt)
|
2011-06-08 |
2020-11-10 |
Shire Human Genetic Therapies, Inc. |
composições, mrna que codifica para uma hgla e seu uso, uso de pelo menos uma molécula de mrna e um veículo de transferência e uso de um mrna que codifica para proteína exógena
|
|
AU2012267578B2
(en)
|
2011-06-08 |
2017-04-20 |
Translate Bio, Inc. |
Cleavable lipids
|
|
US9862926B2
(en)
|
2011-06-27 |
2018-01-09 |
Cellscript, Llc. |
Inhibition of innate immune response
|
|
CN103781900A
(zh)
*
|
2011-06-30 |
2014-05-07 |
西格马-奥尔德里奇有限责任公司 |
缺乏CMP-N-乙酰神经氨酸羟化酶和/或糖蛋白α-1，3-半乳糖基转移酶的细胞
|
|
EP3384938A1
(en)
|
2011-09-12 |
2018-10-10 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
|
WO2013039857A1
(en)
|
2011-09-12 |
2013-03-21 |
modeRNA Therapeutics |
Engineered nucleic acids and methods of use thereof
|
|
US9464124B2
(en)
|
2011-09-12 |
2016-10-11 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
|
AU2012318249B2
(en)
|
2011-10-05 |
2016-04-21 |
Protiva Biotherapeutics Inc. |
Compositions and methods for silencing aldehyde dehydrogenase
|
|
CN107522664B
(zh)
|
2011-10-27 |
2021-03-16 |
麻省理工学院 |
能够形成药物包封微球的在n末端上官能化的氨基酸衍生物
|
|
WO2013130161A1
(en)
|
2011-12-14 |
2013-09-06 |
modeRNA Therapeutics |
Methods of responding to a biothreat
|
|
US20140343129A1
(en)
|
2011-12-14 |
2014-11-20 |
Moderna Therapeutics, Inc. |
Modified nucleic acids, and acute care uses thereof
|
|
EP2791160B1
(en)
|
2011-12-16 |
2022-03-02 |
ModernaTX, Inc. |
Modified mrna compositions
|
|
WO2013096709A2
(en)
|
2011-12-21 |
2013-06-27 |
modeRNA Therapeutics |
Methods of increasing the viability or longevity of an organ or organ explant
|
|
WO2013101690A1
(en)
|
2011-12-29 |
2013-07-04 |
modeRNA Therapeutics |
Modified mrnas encoding cell-penetrating polypeptides
|
|
EP3677678B1
(en)
|
2011-12-30 |
2024-01-31 |
Cellscript, Llc |
Making and using in vitro-synthesized ssrna for introducing into mammalian cells to induce a biological or biochemical effect
|
|
EP3988104A1
(en)
|
2012-02-24 |
2022-04-27 |
Arbutus Biopharma Corporation |
Trialkyl cationic lipids and methods of use thereof
|
|
JP6283655B2
(ja)
|
2012-03-29 |
2018-02-21 |
シャイアー ヒューマン ジェネティック セラピーズ インコーポレイテッド |
イオン化可能なカチオン性脂質
|
|
JP6211054B2
(ja)
|
2012-03-29 |
2017-10-11 |
シャイアー ヒューマン ジェネティック セラピーズ インコーポレイテッド |
脂質誘導される中性ナノ粒子
|
|
AU2013243946A1
(en)
|
2012-04-02 |
2014-10-30 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of membrane proteins
|
|
US9283287B2
(en)
|
2012-04-02 |
2016-03-15 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of nuclear proteins
|
|
US9572897B2
(en)
|
2012-04-02 |
2017-02-21 |
Modernatx, Inc. |
Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
|
|
US20150050354A1
(en)
|
2012-04-02 |
2015-02-19 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the treatment of otic diseases and conditions
|
|
US9303079B2
(en)
|
2012-04-02 |
2016-04-05 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
|
|
US20140275229A1
(en)
|
2012-04-02 |
2014-09-18 |
Moderna Therapeutics, Inc. |
Modified polynucleotides encoding udp glucuronosyltransferase 1 family, polypeptide a1
|
|
AU2013243949A1
(en)
|
2012-04-02 |
2014-10-30 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of biologics and proteins associated with human disease
|
|
EP2859102A4
(en)
|
2012-06-08 |
2016-05-11 |
Shire Human Genetic Therapies |
NUCLEASE RESISTANT POLYNUCLEOTIDES AND USES THEREOF
|
|
EA201492055A1
(ru)
|
2012-06-08 |
2015-11-30 |
Шир Хьюман Дженетик Терапис, Инк. |
ИНГАЛЯЦИОННАЯ ДОСТАВКА мРНК В НЕЛЕГОЧНЫЕ КЛЕТКИ-МИШЕНИ
|
|
EP2674167A1
(en)
|
2012-06-14 |
2013-12-18 |
PLS-Design GmbH |
Controlled activation of complement components for use as endogenous adjuvant
|
|
CA2884870C
(en)
|
2012-08-13 |
2022-03-29 |
Massachusetts Institute Of Technology |
Amine-containing lipidoids and uses thereof
|
|
US20140093952A1
(en)
|
2012-10-02 |
2014-04-03 |
David Serway |
Bioreactor Tangential Flow Perfusion Filter System
|
|
US20150307542A1
(en)
|
2012-10-03 |
2015-10-29 |
Moderna Therapeutics, Inc. |
Modified nucleic acid molecules and uses thereof
|
|
NZ708523A
(en)
*
|
2012-11-21 |
2018-09-28 |
Serum Institute Of India Pvt Ltd |
Production of high yields of bacterial polysaccharides
|
|
LT2922554T
(lt)
|
2012-11-26 |
2022-06-27 |
Modernatx, Inc. |
Terminaliai modifikuota rnr
|
|
US20150366997A1
(en)
|
2012-12-07 |
2015-12-24 |
Shire Human Genetics Therapies, Inc. |
COMPOSITIONS AND METHODS FOR mRNA DELIVERY
|
|
EP2931914A4
(en)
|
2012-12-13 |
2016-08-17 |
Moderna Therapeutics Inc |
MODIFIED POLYNUCLEOTIDES FOR CHANGING THE CELL PHENOTYPE
|
|
JP6449781B2
(ja)
*
|
2013-01-03 |
2019-01-09 |
エクソサム ダイアグノスティクス，インコーポレイティド |
微細小胞の単離方法
|
|
JP2016504050A
(ja)
|
2013-01-17 |
2016-02-12 |
モデルナ セラピューティクス インコーポレイテッドＭｏｄｅｒｎａ Ｔｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ． |
細胞表現型の改変のためのシグナルセンサーポリヌクレオチド
|
|
US20160022774A1
(en)
|
2013-03-12 |
2016-01-28 |
Moderna Therapeutics, Inc. |
Diagnosis and treatment of fibrosis
|
|
EP2968391A1
(en)
|
2013-03-13 |
2016-01-20 |
Moderna Therapeutics, Inc. |
Long-lived polynucleotide molecules
|
|
ES2680595T3
(es)
|
2013-03-14 |
2018-09-10 |
Translate Bio, Inc. |
Evaluación cuantitativa para eficacia de ARN mensajero para tapar
|
|
EP2970940B1
(en)
|
2013-03-14 |
2018-07-25 |
Translate Bio, Inc. |
Mrna therapeutic compositions and use to treat diseases and disorders
|
|
EP3750903A1
(en)
|
2013-03-14 |
2020-12-16 |
Translate Bio, Inc. |
Ribonucleic acids with 4'-thio-modified nucleotides and related methods
|
|
IL305374A
(en)
|
2013-03-14 |
2023-10-01 |
Ethris Gmbh |
CFTR mRNA Assemblies and Related Methods and Uses
|
|
EP2971010B1
(en)
|
2013-03-14 |
2020-06-10 |
ModernaTX, Inc. |
Formulation and delivery of modified nucleoside, nucleotide, and nucleic acid compositions
|
|
US9957499B2
(en)
|
2013-03-14 |
2018-05-01 |
Translate Bio, Inc. |
Methods for purification of messenger RNA
|
|
ES2708562T3
(es)
|
2013-03-14 |
2019-04-10 |
Translate Bio Inc |
Evaluación cuantitativa de la eficacidad de tapa de ARN mensajero
|
|
EP3932947A1
(en)
|
2013-03-14 |
2022-01-05 |
Translate Bio MA, Inc. |
Methods and compositions for delivering mrna coded antibodies
|
|
WO2014144039A1
(en)
|
2013-03-15 |
2014-09-18 |
Moderna Therapeutics, Inc. |
Characterization of mrna molecules
|
|
US10590161B2
(en)
|
2013-03-15 |
2020-03-17 |
Modernatx, Inc. |
Ion exchange purification of mRNA
|
|
US20160017313A1
(en)
|
2013-03-15 |
2016-01-21 |
Moderna Therapeutics, Inc. |
Analysis of mrna heterogeneity and stability
|
|
US10130649B2
(en)
|
2013-03-15 |
2018-11-20 |
Translate Bio, Inc. |
Synergistic enhancement of the delivery of nucleic acids via blended formulations
|
|
US8980864B2
(en)
|
2013-03-15 |
2015-03-17 |
Moderna Therapeutics, Inc. |
Compositions and methods of altering cholesterol levels
|
|
PT2970948T
(pt)
*
|
2013-03-15 |
2019-03-20 |
Glaxosmithkline Biologicals Sa |
Métodos de purificação de arn
|
|
WO2014152027A1
(en)
|
2013-03-15 |
2014-09-25 |
Moderna Therapeutics, Inc. |
Manufacturing methods for production of rna transcripts
|
|
WO2014152031A1
(en)
|
2013-03-15 |
2014-09-25 |
Moderna Therapeutics, Inc. |
Ribonucleic acid purification
|
|
EP2971165A4
(en)
|
2013-03-15 |
2016-11-23 |
Moderna Therapeutics Inc |
DISSOLUTION OF DNA FRAGMENTS IN MRNA MANUFACTURING METHODS
|
|
WO2014179562A1
(en)
|
2013-05-01 |
2014-11-06 |
Massachusetts Institute Of Technology |
1,3,5-triazinane-2,4,6-trione derivatives and uses thereof
|
|
US9895443B2
(en)
|
2013-06-26 |
2018-02-20 |
Massachusetts Institute Of Technology |
Multi-tailed lipids and uses thereof
|
|
PL3019619T3
(pl)
|
2013-07-11 |
2022-01-10 |
Modernatx, Inc. |
Kompozycje zawierające syntetyczne polinkleotydy kodujące białka powiązane z crispr i syntetyczne sgrna oraz sposoby ich stosowania
|
|
US20160151284A1
(en)
|
2013-07-23 |
2016-06-02 |
Protiva Biotherapeutics, Inc. |
Compositions and methods for delivering messenger rna
|
|
US20160194625A1
(en)
|
2013-09-03 |
2016-07-07 |
Moderna Therapeutics, Inc. |
Chimeric polynucleotides
|
|
US20160194368A1
(en)
|
2013-09-03 |
2016-07-07 |
Moderna Therapeutics, Inc. |
Circular polynucleotides
|
|
US10023626B2
(en)
|
2013-09-30 |
2018-07-17 |
Modernatx, Inc. |
Polynucleotides encoding immune modulating polypeptides
|
|
EP3052479A4
(en)
|
2013-10-02 |
2017-10-25 |
Moderna Therapeutics, Inc. |
Polynucleotide molecules and uses thereof
|
|
WO2015051169A2
(en)
|
2013-10-02 |
2015-04-09 |
Moderna Therapeutics, Inc. |
Polynucleotide molecules and uses thereof
|
|
US20160243221A1
(en)
|
2013-10-18 |
2016-08-25 |
Moderna Therapeutics, Inc. |
Compositions and methods for tolerizing cellular systems
|
|
WO2015061461A1
(en)
|
2013-10-22 |
2015-04-30 |
Shire Human Genetic Therapies, Inc. |
Cns delivery of mrna and uses thereof
|
|
CA2928188A1
(en)
|
2013-10-22 |
2015-04-30 |
Shire Human Genetic Therapies, Inc. |
Mrna therapy for argininosuccinate synthetase deficiency
|
|
EP3574923A1
(en)
|
2013-10-22 |
2019-12-04 |
Translate Bio, Inc. |
Mrna therapy for phenylketonuria
|
|
EP3076994A4
(en)
|
2013-12-06 |
2017-06-07 |
Modernatx, Inc. |
Targeted adaptive vaccines
|
|
US20150167017A1
(en)
|
2013-12-13 |
2015-06-18 |
Moderna Therapeutics, Inc. |
Alternative nucleic acid molecules and uses thereof
|
|
US20170002060A1
(en)
|
2014-01-08 |
2017-01-05 |
Moderna Therapeutics, Inc. |
Polynucleotides for the in vivo production of antibodies
|
|
EP3981437A1
(en)
|
2014-04-23 |
2022-04-13 |
ModernaTX, Inc. |
Nucleic acid vaccines
|
|
ES2750661T3
(es)
*
|
2014-04-25 |
2020-03-26 |
Translate Bio Inc |
Métodos para la purificación de ARN mensajero
|
|
JP6347163B2
(ja)
|
2014-07-10 |
2018-06-27 |
株式会社リコー |
定着装置及び画像形成装置
|
|
AU2015328012A1
(en)
|
2014-10-02 |
2017-05-11 |
Arbutus Biopharma Corporation |
Compositions and methods for silencing Hepatitis B virus gene expression
|
|
WO2016071857A1
(en)
|
2014-11-07 |
2016-05-12 |
Protiva Biotherapeutics, Inc. |
Compositions and methods for silencing ebola virus expression
|
|
US20170362627A1
(en)
|
2014-11-10 |
2017-12-21 |
Modernatx, Inc. |
Multiparametric nucleic acid optimization
|
|
WO2016077125A1
(en)
|
2014-11-10 |
2016-05-19 |
Moderna Therapeutics, Inc. |
Alternative nucleic acid molecules containing reduced uracil content and uses thereof
|
|
WO2016118724A1
(en)
|
2015-01-21 |
2016-07-28 |
Moderna Therapeutics, Inc. |
Lipid nanoparticle compositions
|
|
WO2016118725A1
(en)
|
2015-01-23 |
2016-07-28 |
Moderna Therapeutics, Inc. |
Lipid nanoparticle compositions
|
|
WO2016154127A2
(en)
|
2015-03-20 |
2016-09-29 |
Protiva Biotherapeutics, Inc. |
Compositions and methods for treating hypertriglyceridemia
|
|
WO2016164762A1
(en)
|
2015-04-08 |
2016-10-13 |
Moderna Therapeutics, Inc. |
Polynucleotides encoding low density lipoprotein receptor egf-a and intracellular domain mutants and methods of using the same
|
|
WO2016183366A2
(en)
|
2015-05-12 |
2016-11-17 |
Protiva Biotherapeutics, Inc. |
Compositions and methods for silencing expression of hepatitis d virus rna
|
|
DK3303583T3
(da)
*
|
2015-05-29 |
2020-07-13 |
Curevac Real Estate Gmbh |
Fremgangsmåde til fremstilling og oprensning af rna, omfattende mindst et trin til tangential-flow-filtrering
|
|
US20180245074A1
(en)
|
2015-06-04 |
2018-08-30 |
Protiva Biotherapeutics, Inc. |
Treating hepatitis b virus infection using crispr
|
|
WO2016197133A1
(en)
|
2015-06-04 |
2016-12-08 |
Protiva Biotherapeutics, Inc. |
Delivering crispr therapeutics with lipid nanoparticles
|
|
WO2016201377A1
(en)
|
2015-06-10 |
2016-12-15 |
Moderna Therapeutics, Inc. |
Targeted adaptive vaccines
|
|
US11920174B2
(en)
|
2016-03-03 |
2024-03-05 |
CureVac SE |
RNA analysis by total hydrolysis and quantification of released nucleosides
|
|
MA47605A
(fr)
|
2017-02-27 |
2020-01-01 |
Translate Bio Inc |
Procédés de purification d'arn messager
|
|
KR20210125536A
(ko)
|
2019-02-11 |
2021-10-18 |
에트리스 게엠베하 |
접선 유동 여과에 의한 mRNA 정제
|